High interferon signaling could induce high expressions of PD-L1 and MHC-II in tumor cells, which bind to PD-1 and LAG3 on the surface of T cells, respectively, and results in reduced CAR-T cell expansion and increased exhaustion [73]. The gene discussed is LAG3; the disease is neoplasm.